Is Hercules Capital HTGC stock risky Q4 2025 EPS Misses Views ESS Essex Property Trust Inc posts 64 percent Q4 2025 revenue growth shares dip 147 percent on double digit EPS miss Ares Mgmt ARES YearAhead Outlook Q4 2025 Earnings Underperform High Energy Costs Threaten Europes AI Competitiveness Against US and China Lifeward LFWD Q1 2026 Earnings Miss by Significant Key Takeaways Jim Cramer Praises NVIDIAs Jensen Huang No AI Revolution Without Him Gold at 4500 an Ounce Sparks American Gold Rush With Prospectors Reporting Significant Finds Stock Market Futures Edge Higher as US Targets Iran Defense Stocks Like Elbit Systems in Focus Powell Vows No Shadow Chair Role but Return of Former Fed Leader Warsh Could Stir Tensions Senteon Integrates with Rewst to Automate Endpoint Hardening for MSPs SpaceXs Public Debut Raises Sector Classification Question Industrials Tech or Telecommunications Ubers Takeover Bid for Delivery Hero Reportedly Rejected Vestas Wind Systems Shares Decline After Company Warns Margins at Low End of Guidance Markel Group Inc MKL Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Results Weigh LPLA Q1 2026 Earnings Slight EPS Beat Amid Negative Market Reaction ELS Q1 2026 Earnings Modest EPS Beat and Steady Market Response WSFS Financial Q1 2026 Earnings EPS Surpasses Estimates by 122 Stock Unchanged IMCC Q1 2026 Earnings Widening Loss Amid Unreported Revenue Highlights Persistent Challenges Tao Synergies Inc TAOX Q4 2024 Earnings Earnings Miss as Losses Widen Amid Operational Uncertainty BRKRP Surges 33 as Bullish Momentum Builds for Bruker Preferred Shares Rezolve AI RZLV Dips 192 as Stock Approaches Support Zone PubMatic PUBM Edges Higher as AdTech Sector Stabilizes abrdn Australia Equity Fund Inc IAF Holds Steady Near Midpoint of Trading Range Jefferson Capital JCAP Edges Lower Amid Mild Selling Pressure Worker Confidence at Record Low as AI Job Disruption Intensifies Global Report Reveals Compugen Ltd Q1 2026 Earnings Narrowing Losses but Misses Estimates GSK GSK Holds Steady With Modest Gains as Pharma Sector Navigates Uncertainty